Acesion Pharma Commences Phase 1 Study in Atrial Fibrillation
Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...
top of page
- Feb 8, 2018
- 2 min
Acesion Pharma Receives Approval for Phase I Study in Atrial Fibrillation
Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...
57 views
- Nov 25, 2016
- 1 min
Acesion Pharma has won the prize as EY Entrepreneur of the Year 2016 in lifescience
Acesion Pharma has won the prize as EY Entrepreneur of the Year 2016 among the nominated Danish Lifesciences companies. The award was...
20 views
LATEST NEWS
bottom of page